In hematologic malignancies such as T-cell acute lymphoblastic leukemia (T-ALL), pharmacological inhibition of the JAK-STAT pathway induces cell death in mutant cells that express IL-7Rα [46]. This evidence concerns the gene IL7R and acute lymphoblastic leukemia.